New Mexico biotechnology company receives investment for Alzheimer's blood test
TNeuro's platform is based on research from Christopher Wheeler, TNeuroPharma's chief science officer, which started when he was working for Cedars-Sinai in Los Angeles.
More from New Mexico Business
Alburquerque Business Journal
TXNM Energy announces CEO transition amid acquisition talks with Blackstone
New Mexico Business
•
May 15, 2025
Alburquerque Business Journal
X-Bow Systems secures $105M in Series B funding, inks strategic deal with Lockheed Martin
New Mexico Business
•
May 13, 2025
Alburquerque Business Journal
From candy striper to administrator: Judi Everett's journey in cardiovascular care
New Mexico Business
•
May 13, 2025
Alburquerque Business Journal
Hyatt Regency Tamaya unveils $15M renovations, modernizing over 300 rooms
New Mexico Business
•
May 11, 2025
Alburquerque Business Journal
CNM names Chris Pendleton as first chief marketing officer
New Mexico Business
•
May 10, 2025
Alburquerque Business Journal
New Mexico's most educated ZIP codes amid graduation rate decline
New Mexico Business
•
May 9, 2025
Alburquerque Business Journal
Developer offers flexible commercial parcels near surging Los Diamantes project
New Mexico Business
•
May 9, 2025
Alburquerque Business Journal
Permian Resources acquires APA's New Mexico acreage
New Mexico Business
•
May 9, 2025